US Edition
After 40 Years, Heart Doctors Say Beta Blockers May Do More Harm Than Good
A study of over 8,500 Spanish and Italian heart attack patients found limited benefits of beta-blockers overall, with increased mortality risk observed in women with normal heart function.
4 Articles
4 Articles
After 40 Years, Heart Doctors Say Beta Blockers May Do More Harm Than Good
For over 40 years, beta blockers have been prescribed to heart attack survivors as a standard treatment. But the massive REBOOT trial has revealed they provide no benefit for patients with preserved heart function — and may actually increase risks for women. Standard Treatment Questioned After 40 Years Beta blockers, commonly prescribed for heart conditions [...]
Beta-Blockers Don’t Benefit All Heart Attack Survivors — and May Raise Heart Risks for Women
New research has found that beta-blockers — medications commonly prescribed to lower heart rate and blood pressure — did not offer clear benefits for certain heart attack patients. The study, known as the REBOOT trial, included more than 8,500 people in Spain and Italy who were recovering from a heart attack. All participants had mildly-reduced heart function, but not heart failure.e60dc2a1-f33c-4a05-9b50-8e3e8e597629c9350eb1-f6cb-4ad7-b2ba-1aaf…
sport.es
elcorreogallego.esIt is one of the studies that has more to talk about in recent days. Because of the paradigm shift that it implies. Coordinated by the National Center for Cardiovascular Research (CNIC), in collaboration with the Mario Negri Institute in Milan (Italy), an international clinical trial has shown that beta-blockers, drugs used for decades to treat various cardiac pathologies, do not bring any benefit to patients who have had an uncomplicated myocar…
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
